MODEL VERDICT
Surrozen, Inc. (SRZN)
Relative Valuation•Peer multiples, Monte Carlo simulation & quality-adjusted fair value
Popular:
Composite score derived from valuation, quality, and risk factors
Quantitative model thresholds · For educational and research purposes only
Each row records the model's monthly assessment. High Conviction = the model detected notable undervaluation vs peers. Neutral = no notable divergence was found. The return column shows the actual price change over 90 days for reference. This is a quantitative observation log — not investment advice.
| Date | Assessment | Score | Price | Status | 90d Fwd Return |
|---|---|---|---|---|---|
| May 1, 2026 | NEUTRAL | 0.14 | $33.60 | CURRENT | — |
| Apr 17, 2026 | NEUTRAL | 0.14 | $31.56 | CURRENT | — |
| Apr 16, 2026 | NEUTRAL | 0.14 | $32.02 | CURRENT | — |
Historical model observations for research purposes only. Past quantitative patterns do not predict future results. Not a recommendation to buy, sell, or hold any security.
| Methodology | Fair Value | vs Current | Weight | Quality | Status |
|---|---|---|---|---|---|
| EV To Revenue 9 industry peers | $14.31 | -57.4% | 4% | B | Data |
| Price / Sales 9 industry peers | $3.30 | -90.2% | 3% | B | Model Driven |
| Weighted Output Blended model output | $9.12 | -72.9% | 100% | 56 | SIGNIFICANTLY OVERVALUED |
Cross-sectional regression predicting expected multiples based on growth, margins, ROIC, and beta.
| Multiple | Avg | Median | Min | Max | Std |
|---|---|---|---|---|---|
| P/TBV | 0.94 | 0.50 | 0.27 | 2.06 | 0.97 |
| P/B Ratio | 0.94 | 0.50 | 0.27 | 2.06 | 0.97 |
| P/S Ratio | 18.06 | 3.95 | 1.62 | 48.61 | 26.48 |
Based on our peer multiples analysis with 5 valuation metrics, the model estimates SRZN's fair value at $9.12 vs the current price of $33.60, implying -72.9% downside potential. Model verdict: Significantly Overvalued. Confidence: 56/100. This is a quantitative estimate, not a recommendation.
The blended fair value of $9.12 is calculated using four lenses: industry median multiples (40%), historical multiples (30%), forward estimates (20%), and quality-adjusted multiples (10%). Monte Carlo simulation (10,000 iterations) gives a range of $8.73 (P10) to $13.59 (P90), with a median of $10.52.
SRZN's current P/E of -1.0x compares to the industry median of 24.9x (5 peers in the group). This represents a -104.2% discount to the industry. The historical average P/E is N/Ax over 0 years. Signal: Deep Discount.
6 analysts cover SRZN with a consensus rating of Buy. The consensus price target is $40.00 (range: $40.00 — $40.00), implying +19.0% upside from the current price. Grade breakdown: Strong Buy (0), Buy (4), Hold (0), Sell (2), Strong Sell (0).
The model confidence score is 56/100, based on: data completeness (6), peer quality (25), historical depth (10), earnings stability (5), and model agreement (10). Cyclicality penalty: -0 points. The model shows moderate agreement across inputs.
The model flags several key risks: (1) Macro/regulatory risks are not captured in this model but remain material.
Peak earnings risk data is not available for SRZN.
No. This dashboard is a quantitative research tool for educational and informational purposes only. It is not investment advice, a solicitation, or a recommendation to buy, sell, or hold any security. The operator of this platform is not a registered investment advisor (RIA), broker-dealer, or financial planner. All model outputs, fair value estimates, signals, and scenarios are the result of automated quantitative computations and should not be construed as professional financial guidance. You should consult a qualified, licensed financial advisor before making any investment decisions. Past model performance is not indicative of future results.